|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Total revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Salaries and Benefits | |||||
| Professional Services | |||||
| Operating expenses | |||||
| Research and development | |||||
| Stock Based Compensation | |||||
| Selling General & Administrative | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest Income | |||||
| Interest Expense – Promissory Notes | |||||
| Interest Expense – Preferred dividends | |||||
| Interest Expense – Financing expenses | |||||
| Net Other income (expense) | |||||
| Non-operating income (expense) | |||||
| Interest and other income, net | |||||
| Interest expense | |||||
| Change in fair value of derivative liability | |||||
| Loss before income tax provision | |||||
| Net Loss | |||||
| Less: Series A convertible preferred stock dividends | |||||
| Net loss attributable to common stockholders | |||||
| Other comprehensive income (loss): | |||||
| Unrealized gain on available-for-sale debt securities (net of tax) | |||||
| Total comprehensive income (loss) | |||||
| Loss per share: | |||||
| Basic (in Dollars per share) | |||||
| Diluted (in Dollars per share) | |||||
| Weighted average shares used in computing net loss per common share: | |||||
| Basic (in Shares) | |||||
| Diluted (in Shares) | |||||
Loading...